| Principal Investigator |
Funding Agency |
Title |
| Bartosh, Sharon |
Abbott Laboratories |
A Phase 3, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Paricalcitol Capsules in Decreasing Serum Intact Parathyroid Hormone Levels in Pediatric Subjects Ages 10 to 16 years with Moderate to Severe Chronic Kidney Disease |
| Bartosh, Sharon |
Abbott Laboratories |
A Prospective, Multicenter Study to Evaluate the Safety of Vitamin D Receptor Activators as Determined by Hypercalcemia in Pediatric Patients ages 0 to 16 with Chronic Kidney Disease (CKD) Stage 5 Receiving Peritoneal Dialysis (PD) within Current Clinical Practice |
| Bartosh, Sharon |
Children's Mercy Hospitals and Clinics |
Chronic Kidney Disease in Children (CKiD) |
| Bartosh, Sharon |
Wayne State University |
Primary Vesicoureteral Reflux - RIVUR |
